Cefiderocol Sulfate Tosylate/Xeruborbactam
- Generic Name
- Cefiderocol Sulfate Tosylate/Xeruborbactam
A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
Phase 1
Recruiting
- Conditions
- Bacterial Infections
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06547554
- Locations
- 🇺🇸
Minneapolis Clinic, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath